上海润达医疗科技股份有限公司 对外担保管理制度 上海润达医疗科技股份有限公司 对外担保管理制度 （二〇二五年八月） 第一章 总 则 第一条 为了规范上海润达医疗科技股份有限公司（下称"公司"）的对 外担保行为，有效防范和控制公司对外担保风险，确保公司资产安全，保护投资 者的合法权益，根据《中华人民共和国公司法》（以下简称"《公司法》"）、 《中华人民共和国证券法》（以下简称"《证券法》"）、《上市公司监管指引 第 8 号——上市公司资金往来、对外担保的监管要求》、《上海证券交易所股票 上市规则》（以下简称"《上市规则》"）等法律、法规、规范性文件以及《上 海润达医疗科技股份有限公司章程》（以下简称"《公司章程》"）的有关规定， 结合公司的实际情况，特制定本制度。 第二条 本制度所称对外担保是指公司为他人提供的担保，包括公司对控 股子公司的担保；本制度所称公司及其控股子公司对外担保总额，是指包括公司 对控股子公司担保在内的公司对外担保总额与公司控股子公司对外担保总额之 和。 担保方式包括但不限于保证、抵押、质押，具体种类包含但不限于借款担保、 银行开立信用证、银行承兑汇票及保函等。 第三条 公司控股子公司的对外 ...

Group 1 - The core viewpoint of the article indicates that RunDa Medical reported a significant decline in revenue and a net loss for the first half of 2025 [1] - The company's operating revenue for the first half of 2025 was 3.47 billion yuan, representing a year-on-year decrease of 16.08% [1] - The net profit attributable to shareholders of the listed company was -121 million yuan, compared to a profit of 91.31 million yuan in the same period last year [1]

Market Overview - The Shanghai Composite Index closed at 3883.56 points, above the six-month moving average, with an increase of 1.51% [1] - The total trading volume of A-shares reached 31,769.48 million yuan [1] Stocks Breaking the Six-Month Moving Average - A total of 83 A-shares have surpassed the six-month moving average today [1] - Notable stocks with significant deviation rates include: - ST Yilianzhong (18.16%) - Kunlun Technology (7.79%) - Huazhi Wine (7.67%) [1] Detailed Stock Performance - The following table summarizes the performance of selected stocks that broke the six-month moving average: | Stock Code | Stock Name | Daily Change (%) | Turnover Rate (%) | Six-Month Average (yuan) | Latest Price (yuan) | Deviation Rate (%) | | --- | --- | --- | --- | --- | --- | --- | | 300096 | ST Yilianzhong | 19.90 | 6.74 | 4.08 | 4.82 | 18.16 | | 831152 | Kunlun Technology | 11.70 | 11.86 | 20.98 | 22.62 | 7.79 | | 300755 | Huazhi Wine | 8.88 | 5.96 | 18.21 | 19.61 | 7.67 | | 600539 | Shitou Co. | 10.02 | 11.47 | 11.30 | 11.97 | 5.94 | | 603198 | Yingjia Wine | 7.22 | 2.79 | 44.61 | 47.08 | 5.54 | | 000002 | Vanke A | 9.15 | 8.16 | 6.81 | 7.16 | 5.20 | | 688646 | ST Yifei | 5.53 | 4.39 | 31.37 | 32.82 | 4.63 | | 003041 | True Love Home | 4.93 | 6.05 | 28.37 | 29.59 | 4.29 | | 839371 | Oufu Industry | 4.59 | 4.82 | 11.15 | 11.62 | 4.20 | | 601933 | Yonghui Supermarket | 5.04 | 5.91 | 5.03 | 5.21 | 3.66 | | 600325 | Huafa Co. | 4.19 | 4.88 | 5.05 | 5.22 | 3.37 | | 601238 | GAC Group | 3.04 | 1.05 | 7.89 | 8.13 | 3.00 | | 600657 | Xinda Real Estate | 3.16 | 2.50 | 4.13 | 4.25 | 2.91 | | 603108 | Runda Medical | 3.00 | 7.99 | 18.43 | 18.90 | 2.54 | | 600988 | Chifeng Gold | 4.03 | 5.40 | 24.67 | 25.30 | 2.54 | | 000069 | Overseas Chinese Town A | 3.86 | 3.88 | 2.36 | 2.42 | 2.44 | | 600872 | Zhongju Gaoxin | 3.29 | 4.97 | 19.37 | 19.78 | 2.14 | | 003000 | Jin Zai Food | 2.46 | 7.48 | 13.07 | 13.35 | 2.13 [1]

Core Insights - The pharmaceutical commercial sector experienced a slight increase of 0.05% on August 22, with Saily Medical leading the gains [1] - The Shanghai Composite Index closed at 3825.76, up 1.45%, while the Shenzhen Component Index closed at 12166.06, up 2.07% [1] Group 1: Stock Performance - Saily Medical (603716) saw a closing price of 31.52, with a significant increase of 10.02% and a trading volume of 614,300 shares, resulting in a transaction value of 1.861 billion yuan [1] - Guofang Co. (600538) closed at 6.55, up 2.18%, with a trading volume of 218,500 shares [1] - Runda Medical (603108) closed at 18.35, up 1.94%, with a trading volume of 303,900 shares [1] - Other notable stocks include Jiuzhoutong (600998) with a slight increase of 0.55% and Yifeng Pharmacy (603939) with a minimal increase of 0.20% [1] Group 2: Capital Flow - The pharmaceutical commercial sector saw a net inflow of 363 million yuan from main funds, while retail investors experienced a net outflow of 114 million yuan [2] - Speculative funds recorded a net outflow of 249 million yuan [2]

Market Performance - The pharmaceutical commercial sector increased by 0.27% on August 15, with RunDa Medical leading the gains [1] - The Shanghai Composite Index closed at 3696.77, up 0.83%, while the Shenzhen Component Index closed at 11634.67, up 1.6% [1] Individual Stock Performance - RunDa Medical (603108) closed at 18.15, up 2.02%, with a trading volume of 228,200 shares and a transaction value of 410 million yuan [1] - Other notable performers included Huaren Health (301408) at 14.77, up 1.79%, and Yixin Pharmacy (002727) at 14.97, up 1.70% [1] - Conversely, Seer Medical (603716) saw a decline of 3.69%, closing at 28.41, with a trading volume of 358,300 shares and a transaction value of 1.017 billion yuan [2] Capital Flow Analysis - The pharmaceutical commercial sector experienced a net outflow of 199 million yuan from institutional investors, while retail investors saw a net inflow of 162 million yuan [2] - The data indicates that retail investors are more active in the sector compared to institutional investors [2] Detailed Capital Flow for Selected Stocks - For 瑞康医药 (002589), the net inflow from institutional investors was 15.82 million yuan, while retail investors had a net outflow of 18.36 million yuan [3] - RunDa Medical (603108) had a net inflow of 7.52 million yuan from institutional investors, but also saw outflows from retail investors [3] - The overall trend shows that while some stocks attract institutional interest, retail investors are more likely to withdraw their investments [3]

Core Insights - RunDa Medical (603108) and Capital Medical University Affiliated Beijing Shijitan Hospital announced the official release of the "Shiyi" medical large model on August 12 [1] - The application of pre-consultation intelligent inquiry can simulate clinical doctor thinking, effectively guiding patients to describe their conditions and symptoms [1] - The application features flexible adaptability for both first-time and follow-up patients, introducing four inquiry modes: "specialty, expert, specific disease, and general," enhancing patient consultation efficiency and experience [1]

Investment Rating - The report does not explicitly provide an investment rating for the thermal printer industry Core Insights - Thermal printers account for over 50% of the total shipment volume in the printer market, making them a mainstream application type [4] - The global thermal printer market is expected to exceed $10 billion by 2030, driven by demand from retail, logistics, healthcare, and manufacturing sectors [20] - The thermal printer market in China is projected to grow rapidly, with an expected increase in global shipment share from approximately 5% in 2024 [21] Summary by Sections Market Overview - Thermal printers are widely used in various sectors including retail, dining, logistics, industrial manufacturing, and healthcare, with a shipment volume share exceeding 50% in the overall printer market [4] - The market share by sales value for thermal printers is approximately 35%, attributed to a wide price range from hundreds to thousands of dollars [4] Advantages of Thermal Printers - Thermal printers offer advantages such as portability, fast printing speed, and low cost, making them suitable for real-time printing scenarios [5] - They do not require ink cartridges or toner, only needing periodic replacement of thermal paper [5] Technological Innovations - Future innovations in the thermal printer industry include dual-color printing and AI integration, enhancing user experience and application versatility [10] Key Components and Domestic Progress - The thermal print head is identified as the core component, directly influencing print quality [16] - There is significant potential for domestic replacement in the thermal print head market, currently dominated by Japanese manufacturers [17] Market Size and Growth - The global thermal printer market size is projected to reach approximately $6.67 billion in 2024, with label printers accounting for nearly 75% of this market [20] - The Chinese market is expected to see a gradual increase in thermal printer shipment share due to rapid development in various industries [21] Competitive Landscape - The global thermal printer market features a clear tiered structure, with leading companies like Zebra and Honeywell dominating the first tier [27] - In China, the market is more fragmented, with domestic companies like TSC and Hanin leading in shipment volume [28]

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 301408 | 华人健康 | 15.11 | -1.76% | 17.96万 | 2.71亿 | | 300937 | 药易购 | 30.05 | -1.60% | 4.53万 | 1.36亿 | | 301015 | 百洋医药 | 25.98 | -1.55% | 29.18万 | 7.77亿 | | 600272 | 开开实业 | 13.87 | -1.42% | 6.94万 | 9642.32万 | | 301126 | 达嘉维康 | 13.25 | -1.41% | 14.39万 | 1.91亿 | | 603122 | 合富中国 | 7.23 | -1.36% | 6.01万 | 4356.44万 | | 002589 | 瑞康医药 | 3.05 | -1.29% | 43.86万 | 1.34亿 | | 301017 | 款玉平民 | 13.20 | -0.98% | 4.94万 | 6532.05万 | | 605266 | 健之佳 ...

Core Viewpoint - The company, Runta Medical, has confirmed that it currently does not have any technology reserves related to brain-computer interface technology [2] Group 1 - An investor inquired about the company's involvement in brain-computer interface technology on an investor interaction platform [2] - Runta Medical responded on August 12, stating that it does not engage in brain-computer interface technology at this time [2]

格隆汇8月12日丨润达医疗(603108.SH)在互动平台表示，公司暂不涉及脑机接口相关技术。 ...